Previous meta-analysis showed no significant correlation between DPP-4 inhibitors and some malignancies, including pancreatic and thyroid cancers.[38,40–42] In the present meta-analysis, the result suggested that DDP-4 inhibitors had a tendency to reduce the incidence of PCa. This evidence concerns the gene DPP4 and thyroid cancer.